Although the umami compound monosodium glutamate (MSG) is a widely used flavor enhancer, controversy still persists regarding the effects of MSG intake on body weight. It has been claimed, in particular, that chronic MSG intake may result in excessive body weight gain and obesity. In this study we assessed the effects of chronic (16 weeks) ad libitum MSG on body weight and metabolism of C57BL6/J mice. Adult male mice were divided in four experimental groups and fed with either a low-fat (LF) or high-fat (HF) diet and with either two bottles of plain water or one bottle containing 1% MSG and another one containing water according to a factorial design. Mice were monitored weekly for body weight and food/fluid intake for 15 weeks. At the end of the experiments, the circulating levels of leptin, insulin, total protein, total cholesterol, triglyceride, blood urea nitrogen, and non-esterified fatty acids were also analyzed. Our results show that MSG intake did not influence body weight in either LF or HF groups. Interestingly, although animals overall displayed strong preferences for MSG against water, preferences were relatively higher in LF compared to HF group. Consistent with the body weight data, while significant differences in leptin, insulin, total cholesterol, and non-esterified fatty acids were found between HF and LF groups, such an effect was not influenced by MSG intake. Finally, indirect calorimetry measurements revealed similar energy expenditure levels between animals being presented water only and MSG only. In summary, our data does not support the notion that ad libitum MSG intake should trigger the development of obesity or other metabolic abnormalities.

Journal Section:
Paper
Keywords:
C57BL6/J mice, weight gain, Indirect calorimetry, Low- and high-fat diets, Monosodium glutamate, Umami-tasting compounds
1.
Jinap S, Hajeb P: Glutamate. Its applications in food and contribution to health. Appetite 2010;55:1–10.
[PubMed]
https://doi.org/10.1016%2Fj.appet.2010.05.002
2.
Hermanussen M, García AP, Sunder M, et al: Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite. Eur J Clin Nutr 2006;60:25–31.
[PubMed]
https://doi.org/10.1038%2Fsj.ejcn.1602263
3.
Iwase M, Ichikawa K, Tashiro K, et al: Effects of monosodium glutamate-induced obesity in spontaneously hypertensive rats vs. Wistar-Kyoto rats: serum leptin and blood flow to brown adipose tissue. Hypertens Res 2000;23:503–510.
[PubMed]
https://doi.org/10.1291%2Fhypres.23.503
4.
Olney JW: Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719–722.
[PubMed]
https://doi.org/10.1126%2Fscience.164.3880.719
5.
Tanaka K, Shimada M, Nakao K, Kusunoki T: Hypothalamic lesion induced by injection of monosodium glutamate in suckling period and subsequent development of obesity. Exp Neurol 1978;62:191–199.
[PubMed]
https://doi.org/10.1016%2F0014-4886%2878%2990050-X
6.
Kondoh T, Torii K: MSG intake suppresses weight gain, fat deposition, and plasma leptin levels in male Sprague-Dawley rats. Physiol Behav 2008;95:135–144.
[PubMed]
https://doi.org/10.1016%2Fj.physbeh.2008.05.010
7.
Ren X, Ferreira JG, Zhou L, et al: Nutrient selection in the absence of taste receptor signaling. J Neurosci 2010;30:8012–8023.
[PubMed]
https://doi.org/10.1523%2FJNEUROSCI.5749-09.2010
8.
Shi Z, Luscombe-Marsh ND, Wittert GA, et al: Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: findings from the Jiangsu Nutrition Study of Chinese adults. Br J Nutr 2010;104:457–463.
[PubMed]
https://doi.org/10.1017%2FS0007114510000760
© 2011 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2011
You do not currently have access to this content.